Compound capable of binding S1P receptor and pharmaceutical use thereof
US8791159B2 · kind B2 · utility
1Cited by
7References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2010 |
| Grant date | Jul 29, 2014 |
| Priority date | — |
| Expiry date | Mar 16, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D217/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound having an ability to bind to an SIP receptor and represented by formula (I), a salt thereof, a solvate thereof or a prodrug thereof is useful for prevention and/or treatment of rejection of transplantation, graft-versus-host disease, autoimmune disease, allergic disease and the like:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.